Coherus BioSciences (CHRS) Fails to deliver data

Key failure to deliver metrics for Coherus BioSciences :

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: NZ$0.13 M
• Last 3 months FTD volume: NZ$0.75 M
• Last year FTD volume: NZ$0.75 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Coherus BioSciences (CHRS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Coherus BioSciences (CHRS) - since 2014

Coherus BioSciences (CHRS) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Acorda Therapeutics ACOR	N/A	NZ$0.01 M	🇺🇸 USA
Arena Pharmaceuticals ARNA	N/A	NZ$0.21 B	🇺🇸 USA
Amgen AMGN	NZ$48.74 M	NZ$0.23 B	🇺🇸 USA
Repligen RGEN	NZ$4.51 M	NZ$56.29 M	🇺🇸 USA